Rating: Not rated
Tags: True Crime, White Collar Crime, Business & Economics, Industries, Pharmaceutical & Biotechnology, Language Arts & Disciplines, Journalism, Science, Biotechnology, General, Social Science, Criminology, Literary Collections, Lang:en
Publisher: Pan Macmillan
Added: July 29, 2018
Modified: November 5, 2021
Summary
'I couldn’t put down this thriller . . . the perfect
book to read by the fire this winter.' Bill Gates, '5 books I
loved in 2018'.Winner of the Financial Times/McKinsey
Business Book of the Year Award 2018.The full inside story of
the breathtaking rise and shocking collapse of Theranos, the
multibillion-dollar biotech startup, by the prize-winning
journalist who first broke the story and pursued it to the
end, despite pressure from its charismatic CEO and threats by
her lawyers.In 2014, Theranos founder and CEO Elizabeth
Holmes was widely seen as the female Steve Jobs: a brilliant
Stanford dropout whose startup "unicorn" promised to
revolutionize the medical industry with a machine that would
make blood testing significantly faster and easier. Backed by
investors such as Larry Ellison and Tim Draper, Theranos sold
shares in a fundraising round that valued the company at more
than $9 billion, putting Holmes's worth at an estimated $4.7
billion. There was just one problem: The technology didn't
work.In Bad Blood, John Carreyrou tells the riveting story of
the biggest corporate fraud since Enron, a tale of ambition
and hubris set amid the bold promises of Silicon Valley.Now
to be adapted into a film, with Jennifer Lawrence to
star.'Chilling . . . Reads like a West Coast version of All
the President’s Men.' New York Times Book Review